Your browser doesn't support javascript.
loading
Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial.
Glewis, Sarah; Alexander, Marliese; Lingaratnam, Senthil; Lee, Benjamin; Campbell, Ian; Krishnasamy, Mei; IJzerman, Maarten; Fagery, Mussab; Harris, Sam; Georgiou, Chloe; Underhill, Craig; Warren, Mark; Campbell, Robert; Martin, Jennifer; Tie, Jeanne; Michael, Michael.
Afiliação
  • Glewis S; Department of Pharmacy, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Alexander M; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
  • Lingaratnam S; Department of Pharmacy, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Lee B; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
  • Campbell I; Department of Pharmacy, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Krishnasamy M; Department of Pharmacy, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • IJzerman M; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
  • Fagery M; Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Harris S; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
  • Georgiou C; Academic Nursing Unit, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Underhill C; VCCC Alliance, Parkville, Australia.
  • Warren M; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
  • Campbell R; Cancer Research, University of Melbourne, Parkville, Australia.
  • Martin J; Melbourne School of Population and Global Health, Centre for Health Policy, University of Melbourne, Parkville, Australia.
  • Tie J; Cancer Research, University of Melbourne, Parkville, Australia.
  • Michael M; Department of Medical Oncology, Bendigo Health, Bendigo, Australia.
Acta Oncol ; 61(9): 1136-1139, 2022 09.
Article em En | MEDLINE | ID: mdl-35972781

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Heterocíclicos / Neoplasias Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Heterocíclicos / Neoplasias Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article